Author

E. K. Alidjinou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Biela· 1 shared A. Danneels· 1 shared A. Dendooven· 1 shared A. Duhamel· 1 shared A. Goffard· 1 shared A. Machelart· 1 shared A. Sobaszek· 1 shared A. Vandeputte· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Biela

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

J. Demaret, B. Corroyer-Simovic, E. K. Alidjinou, A. Goffard, J. Trauet, S. Miczek, F. Vuotto, A. Dendooven, D. Huvent-Grelle, J. Podvin, D. Dreuil, K. Faure, D. Deplanque, L. Bocket, A. Duhamel, , G. Lefevre

This study compares antibody and T cell memory responses to the BNT162b2 vaccine in older adults with and without prior SARS-CoV-2 infection, finding impaired responses in naive older adults and suggesting an additional dose may be needed.

bioRxiv · Jul 8, 2021 · PreprintImmunology

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

S. Belouzard, A. Machelart, V. Sencio, T. Vausselin, E. Hoffmann, N. Deboosere, Y. Rouille, L. Desmarets, K. Seron, A. Danneels, C. Robil, L. Belloy, C. Moreau, C. Piveteau, A. Biela, , J. Dubuisson

This paper identifies clofoctol as an antiviral against SARS-CoV-2, showing it inhibits viral replication and reduces lung pathology in mice.

bioRxiv · Jun 30, 2021 · PreprintMicrobiology